Sanofi Dupixent under USFDA priority review for eosinophilic esophagitis patients Ruchika Sharma5 April 2022 6:00 AMParis: Sanofi has recently announced that the U.S. Food and Drug Administration (USFDA) has accepted for Priority Review the supplemental Biologics...
Sanofi Gets CDSCO panel okay for retrospective study of Insulin Glargine Dr. Divya Colin2 April 2022 12:35 PMNew Delhi: Pharmaceutical major, Sanofi has got the go-head from the Subject Expert Committee (SEC) functional under Central Drug Standard Control...
Sanofi offers Rs 10,000 crores bond linked to access medicine MD Bureau1 April 2022 9:36 AMThe company said the costs of financing would be linked to achieving concrete targets in terms of a cumulative number of patients being provided with...
Sanofi, IGM Biosciences collaborate for oncology, immunology, inflammation targets Ruchika Sharma1 April 2022 4:30 AMParis: Sanofi and IGM Biosciences, Inc. have announced the signing of an exclusive worldwide collaboration agreement to create, develop, manufacture,...
Sanofi targets eczema-treatment product Dupixent peak sales of over 13 billion euros Ruchika Sharma29 March 2022 7:51 AMParis: French healthcare group Sanofi, which lagged rivals in the race for COVID-19 vaccines, raised on Tuesday its peak sales target for...
Sanofi gets Japenese nod for Xenpozyme to treat acid sphingomyelinase deficiency Ruchika Sharma28 March 2022 4:00 AMXenpozyme is a recombinant human acid sphingomyelinase enzyme developed to replace deficient or defective acid sphingomyelinase (ASM)
Sanofi joins hands with Prellis Biologics MD Bureau24 March 2022 4:00 AMSan Francisco: Prellis Biologics, Inc., a Bay Area biotherapeutics company, has announced that the company has entered into a collaboration and...
Sanofi and Seagen announce collaboration to develop and commercialize multiple novel antibody-drug conjugates MD Bureau18 March 2022 10:30 AMSeagen and Sanofi will co-fund global development activities and share equally in any future profits. In addition, Sanofi will make an undisclosed...
Sanofi announces €300 million collaboration with Blackstone Life Sciences MD Bureau17 March 2022 5:13 AMFor the Sarclisa subcutaneous formulation delivery, Sanofi has partnered with drug delivery technology innovator company Enable Injections, Inc. to...
16/March/2022 Top Health Bulletin Roshni Dhar16 March 2022 1:15 PMHere are top health stories for today:Doon hospital fined Rs 12.5L for 'wrong treatment' of patientA fine of Rs 12.five lakh on a 1.1 Dehradun-based...
Sanofi, Sobi announce results of XTEND-1 phase 3 study of efanesoctocog alfa MD Bureau13 March 2022 9:00 AMThe study met the primary endpoint, showing a clinically meaningful prevention of bleeds in people with severe hemophilia A receiving weekly...
Sanofi gets CDSCO panel okay to market Quadrivalent Inactivated Influenza vaccine Dr. Divya Colin12 March 2022 8:17 AMNew Delhi: Pharma major, Sanofi has got the go-head from the Subject Expert Committee (SEC) of the Central Drug Standard Control Organization (CDSCO)...
